Table 1. Most recent bisphosphonate claim among all users.
| Drug (route) | N | % |
|---|---|---|
| Alendronate / alendronic acid (oral) | 340,810 | 75.4% |
| Etidronate (oral) | 14 | 0.0% |
| Ibandronate / ibandronic acid (oral) | 37,988 | 8.4% |
| Ibandronic acid (injection/infusion) | 1169 | 0.3% |
| Pamidronate (injection/infusion) | 1121 | 0.2% |
| Risedronate (oral) | 18,991 | 4.2% |
| Zoledronic acid (injection/infusion) | 51,958 | 11.5% |